Skip to main content
. Author manuscript; available in PMC: 2012 Apr 1.
Published in final edited form as: Clin Microbiol Infect. 2011 Apr;17(4):539–545. doi: 10.1111/j.1469-0691.2010.03277.x

Table 2.

In vitro antimicrobial susceptibility rates of Enterobacter species bloodstream isolates, 1998-2007.

Antimicrobial Number of susceptible isolates/number of isolates tested Susceptibility %
Ceftazidime 33/38 87
Piperacillin-tazobactam 33/37 89
Ciprofloxacin 36/38 95
Levofloxacin 35/37 95
Trimethoprim-sulfamethoxazole 37/38 97
Gentamicin 38/38 100
Cefepime 37/37 100
Imipenem 37/37 100
Meropenem 37/37 100